• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Solution-induced corneal staining is a sign to be taken seriously


Solution-induced corneal staining is a relatively common finding in contact lens wearers that must be taken seriously because it is a sign of corneal compromise that may lead to infiltrative keratitis.

"Findings from laboratory studies measuring fluorescein dye diffusion to evaluate corneal barrier function provide objective evidence that SICS has physiological consequences," said Dr. Paugh, professor and associate dean of research, Southern California College of Optometry, Fullerton, CA.

"With repeated insult to the cornea, certain sensitive individuals may develop inflammation that can lead to infiltrative keratitis," he continued.

Induced hapten mechanism

Reported rates of SICS, based on data from randomized, controlled clinical trials, range from about 2% to 7%. There is evidence that SICS increases the risk of infiltrative keratitis threefold. The process whereby SICS progresses to infiltrative keratitis has not been definitively established, but Dr. Paugh proposed that it may develop over the longer term, via a hapten mechanism, in patients who are sensitive to repeated toxic or noxious insults.

According to this theory, a chemical entity from the care solution acts as a hapten (a partial antigen), where it may combine with a tissue protein on the ocular surface to become a full antigen that induces an immune response, that is, a type IV delayed hypersensitivity reaction.

"Research establishes this mechanism occurs with thimerosal, although further study is needed to demonstrate its relevance with newer preservatives," Dr. Paugh said.

The clinical features evolve with the progression from short-term solution toxicity to an immune response. Initially, patients present with diffuse, punctate staining, symptoms of irritation (primarily burning), and bright red bulbar injection. Infiltrates are usually absent. However, if an immune response develops, itching becomes the major symptom. The redness of the eye becomes paler, staining is minimal, and infiltrates are always present.

"SICS is important because it can lead to infiltrative keratitis, but even in the short-term, its related discomfort causes unhappy patients," he said.

Related Videos
Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
© 2024 MJH Life Sciences

All rights reserved.